Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy

Despite progress in the treatment of diabetic macular edema and diabetic retinopathy, the rate of lower fundus examination due to limitations of medical resources delays the diagnosis and treatment of diabetic retinopathy. Therefore, implementation of automated diabetic retinopathy screening program...

Full description

Saved in:
Bibliographic Details
Published inJournal of diabetes investigation Vol. 12; no. 8; pp. 1322 - 1325
Main Authors Lin, Kuan‐Yu, Hsih, Wen‐Hui, Lin, Yen‐Bo, Wen, Chen‐Yu, Chang, Tien‐Jyun
Format Journal Article
LanguageEnglish
Published Japan John Wiley & Sons, Inc 01.08.2021
John Wiley and Sons Inc
Wiley
Subjects
Automation
Biomarkers
Blood pressure
Clinical medicine
Clinical trials
Diabetes
Diabetes mellitus
Diabetes Mellitus - epidemiology
Diabetes retinopathy
Diabetic retinopathy
Diabetic Retinopathy - diagnosis
Diabetic Retinopathy - epidemiology
Diabetic Retinopathy - therapy
Edema
Epidemiology
Humans
Hyperglycemia
Hypertension
JDI Updates
Lasers
Mass Screening
Neurodegeneration
Prevalence
Retinopathy
Risk Factors
Screening
Telemedicine
Treatment
Vascular endothelial growth factor
Vision
Visual impairment
Screening
Diabetes retinopathy
Treatment
Epidemiology
Risk factors
Online AccessGet full text

Cover

Abstract Despite progress in the treatment of diabetic macular edema and diabetic retinopathy, the rate of lower fundus examination due to limitations of medical resources delays the diagnosis and treatment of diabetic retinopathy. Therefore, implementation of automated diabetic retinopathy screening program and the identification of more specific and sensitive biomarkers are important for facilitating the earlier detection of diabetic macular edema and diabetic retinopathy to decrease the prevalence of poor vision and blindness.
AbstractList Despite progress in the treatment of diabetic macular edema and diabetic retinopathy, the rate of lower fundus examination due to limitations of medical resources delays the diagnosis and treatment of diabetic retinopathy. Therefore, implementation of automated diabetic retinopathy screening program and the identification of more specific and sensitive biomarkers are important for facilitating the earlier detection of diabetic macular edema and diabetic retinopathy to decrease the prevalence of poor vision and blindness.
Despite the above mentioned risk factors, studies revealed a substantial variation in the development and severity of diabetic retinopathy that could not be fully explained by the known risk factors. [...]identifying more biomarkers to stratify the risk or to evaluate the therapeutic response of diabetic retinopathy is important. [...]a timely screening program for diabetic retinopathy could assist individuals with diabetes to preserve their vision. According to current guidelines for the screening of diabetic retinopathy, reported by the International Council of Ophthalmology (ICO) and American Diabetes Association (ADA) in 2018, the timing of the first eye examination and minimum screening examinations are required for appropriate referral to an ophthalmologist 27,28. Since 2010, several large randomized trials have demonstrated the efficacy of all three anti-VEGF agents in the reduction of diabetic macular edema and in the improvement of vision 35–40.
Despite progress in the treatment of diabetic macular edema and diabetic retinopathy, the rate of lower fundus examination due to limitations of medical resources delays the diagnosis and treatment of diabetic retinopathy. Therefore, implementation of automated diabetic retinopathy screening program and the identification of more specific and sensitive biomarkers are important for facilitating the earlier detection of diabetic macular edema and diabetic retinopathy to decrease the prevalence of poor vision and blindness.Despite progress in the treatment of diabetic macular edema and diabetic retinopathy, the rate of lower fundus examination due to limitations of medical resources delays the diagnosis and treatment of diabetic retinopathy. Therefore, implementation of automated diabetic retinopathy screening program and the identification of more specific and sensitive biomarkers are important for facilitating the earlier detection of diabetic macular edema and diabetic retinopathy to decrease the prevalence of poor vision and blindness.
Author Lin, Yen‐Bo
Hsih, Wen‐Hui
Lin, Kuan‐Yu
Chang, Tien‐Jyun
Wen, Chen‐Yu
AuthorAffiliation 1 Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan
AuthorAffiliation_xml – name: 1 Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan
Author_xml – sequence: 1
  givenname: Kuan‐Yu
  surname: Lin
  fullname: Lin, Kuan‐Yu
  organization: National Taiwan University Hospital
– sequence: 2
  givenname: Wen‐Hui
  surname: Hsih
  fullname: Hsih, Wen‐Hui
  organization: National Taiwan University Hospital
– sequence: 3
  givenname: Yen‐Bo
  surname: Lin
  fullname: Lin, Yen‐Bo
  organization: National Taiwan University Hospital
– sequence: 4
  givenname: Chen‐Yu
  surname: Wen
  fullname: Wen, Chen‐Yu
  organization: National Taiwan University Hospital
– sequence: 5
  givenname: Tien‐Jyun
  orcidid: 0000-0001-9437-5847
  surname: Chang
  fullname: Chang, Tien‐Jyun
  email: tjc922@gmail.com
  organization: National Taiwan University Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33316144$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1vGyEQhldVqiZNc-gfqJB6aSQ7gYUF9lKpSvrhKlIv6aUXxMJg467BBdzK_744Tq0mUjsHQPDOo3eYed4chRigaV4SfEFqXC6tvyCUSfykOWkxw1NCWnZ0OBN-3JzlvMQ1qJSci2fNMaWUcMLYSfPt69rqAsgHVBaAYO0trHwc43w7Qcnn78hpU2LKE5RNAgg-zCdIB4tKAl1WEAqKDlmvByjeoFTXENe6LLYvmqdOjxnO7vfT5vbD-9urT9ObLx9nV-9upqajFE-d7IW0zvTDILgAZ9q2o8YCF9hxkLjTtgXRDqJjTnSDlGIQQ99jxi30rKOnzWyPtVEv1Tr5lU5bFbVXdxcxzZVO1doIqjO9ADFwOThgfU8k17h-CHVEMsoHUllv96z1ZliBNbW6pMcH0IcvwS_UPP5UknaM9W0FvLkHpPhjA7molc8GxlEHiJusWiZwK2traJW-fiRdxk0K9adU23U9l1KynaNXfzs6WPnTwSo43wtMijkncAcJwWo3IKoOiLobkKq9fKQ1vuji464YP_4v45cfYftvtPp8Pdtn_AY7Tsry
CitedBy_id crossref_primary_10_1515_hmbci_2023_0081
crossref_primary_10_1186_s40942_024_00615_8
crossref_primary_10_1111_jdi_70016
crossref_primary_10_1186_s40001_025_02473_y
crossref_primary_10_3389_fcell_2025_1550176
crossref_primary_10_7759_cureus_28227
crossref_primary_10_1007_s13340_024_00724_7
crossref_primary_10_2147_DMSO_S420253
crossref_primary_10_1111_omi_12449
crossref_primary_10_3389_fendo_2023_1132036
crossref_primary_10_3390_metabo12121244
crossref_primary_10_3389_fendo_2023_1184717
crossref_primary_10_3390_cells13221864
crossref_primary_10_1371_journal_pone_0291280
crossref_primary_10_35339_ekm_2021_90_3_sts
crossref_primary_10_3389_fmicb_2024_1359949
crossref_primary_10_1007_s00417_025_06793_x
crossref_primary_10_3389_fpubh_2023_1128008
crossref_primary_10_3390_ijms26031094
crossref_primary_10_1016_j_acthis_2023_152069
crossref_primary_10_3390_jcm12216719
crossref_primary_10_3389_fmed_2023_1246936
crossref_primary_10_3390_nu16183169
crossref_primary_10_12998_wjcc_v12_i16_2813
crossref_primary_10_3389_fendo_2022_1036735
crossref_primary_10_3389_fendo_2024_1364609
crossref_primary_10_1016_j_japh_2024_102254
crossref_primary_10_3390_nu15092031
crossref_primary_10_35339_msz_2021_90_4_sst
crossref_primary_10_3389_fphar_2025_1521358
crossref_primary_10_1007_s13167_023_00314_8
crossref_primary_10_1007_s42600_023_00297_5
crossref_primary_10_2147_DMSO_S467799
crossref_primary_10_3389_fendo_2022_869519
crossref_primary_10_1080_24701556_2024_2355366
crossref_primary_10_3389_fendo_2024_1404157
crossref_primary_10_1097_MD_0000000000040896
crossref_primary_10_12677_ACM_2023_1361335
crossref_primary_10_1007_s13410_024_01396_4
crossref_primary_10_1016_j_aohep_2024_101478
crossref_primary_10_3389_fgene_2023_1296773
crossref_primary_10_3389_fpubh_2022_1033495
crossref_primary_10_3233_JAD_230791
crossref_primary_10_1007_s10863_024_10016_z
crossref_primary_10_1016_j_jdiacomp_2024_108808
crossref_primary_10_56712_latam_v5i5_2723
crossref_primary_10_1016_j_asjsur_2024_10_086
crossref_primary_10_3923_ijp_2024_174_185
crossref_primary_10_1007_s00592_024_02355_5
crossref_primary_10_1186_s40662_024_00389_y
crossref_primary_10_26724_2079_8334_2024_3_89_245_250
crossref_primary_10_1016_j_taap_2024_117214
crossref_primary_10_3389_fopht_2023_1230581
crossref_primary_10_3389_fendo_2024_1359255
crossref_primary_10_3390_ijms25042405
crossref_primary_10_2147_DMSO_S470297
crossref_primary_10_1177_11206721241248868
crossref_primary_10_1080_02713683_2023_2265079
crossref_primary_10_2147_DMSO_S413915
crossref_primary_10_1016_j_ajpath_2023_02_017
crossref_primary_10_1038_s41598_024_63916_w
crossref_primary_10_14336_AD_2023_0621
crossref_primary_10_3390_antiox13050594
crossref_primary_10_37990_medr_1191976
crossref_primary_10_1016_j_oftale_2023_11_014
crossref_primary_10_2147_DMSO_S455428
crossref_primary_10_1038_s41598_024_51749_6
crossref_primary_10_3390_jcm11143945
crossref_primary_10_3390_jcm13051327
crossref_primary_10_1186_s40246_024_00637_1
crossref_primary_10_1016_j_phymed_2024_155568
crossref_primary_10_1016_j_dsx_2024_103050
crossref_primary_10_1111_opo_13439
crossref_primary_10_22141_2309_8147_11_2_2023_327
crossref_primary_10_1007_s40123_023_00753_6
crossref_primary_10_1016_j_bbadis_2023_166839
crossref_primary_10_1007_s00417_022_05843_y
crossref_primary_10_1080_13813455_2023_2274279
crossref_primary_10_1186_s12886_022_02762_8
crossref_primary_10_3389_fendo_2023_1104963
crossref_primary_10_3389_fnagi_2024_1517368
crossref_primary_10_3341_jkos_2023_64_12_1208
crossref_primary_10_1515_revneuro_2023_0130
crossref_primary_10_1007_s00417_024_06472_3
crossref_primary_10_1364_BOE_472176
crossref_primary_10_3390_genes15121596
crossref_primary_10_4239_wjd_v15_i4_654
crossref_primary_10_1007_s00592_024_02345_7
crossref_primary_10_3389_fendo_2023_1195354
crossref_primary_10_1016_j_mvr_2023_104556
crossref_primary_10_2147_DMSO_S504308
crossref_primary_10_1016_j_ajo_2024_07_012
crossref_primary_10_3390_ijms251910485
crossref_primary_10_7759_cureus_77606
crossref_primary_10_62151_2786_9288_1_2_2023_02
crossref_primary_10_1016_j_jtos_2023_12_002
crossref_primary_10_1371_journal_pone_0312565
crossref_primary_10_2147_DMSO_S399910
crossref_primary_10_4239_wjd_v15_i8_1734
crossref_primary_10_5937_medi56_42397
crossref_primary_10_1016_j_imlet_2024_106863
crossref_primary_10_3390_ijms24021024
crossref_primary_10_3390_antiox13040423
crossref_primary_10_3390_metabo15030184
crossref_primary_10_1007_s00210_024_03213_5
crossref_primary_10_3390_ijms252312631
crossref_primary_10_4239_wjd_v15_i7_1531
crossref_primary_10_1007_s00592_022_01951_7
crossref_primary_10_4239_wjd_v15_i12_2302
crossref_primary_10_2147_DMSO_S437580
crossref_primary_10_2147_DMSO_S437586
crossref_primary_10_1016_j_jdiacomp_2022_108259
crossref_primary_10_1007_s11845_023_03365_y
crossref_primary_10_3389_fpubh_2023_1106728
crossref_primary_10_3389_fendo_2023_1144422
crossref_primary_10_3389_fgene_2025_1548147
crossref_primary_10_1007_s00592_024_02400_3
crossref_primary_10_1016_j_archger_2024_105687
crossref_primary_10_1016_j_pcd_2024_12_007
crossref_primary_10_12968_hmed_2024_0216
crossref_primary_10_1080_09286586_2024_2434247
crossref_primary_10_1055_a_2279_7112
crossref_primary_10_1155_2023_7355039
crossref_primary_10_1038_s41598_024_56777_w
crossref_primary_10_3390_ijms242015199
crossref_primary_10_1007_s10792_024_03360_x
crossref_primary_10_1016_j_exer_2024_109912
crossref_primary_10_1080_02713683_2023_2204208
crossref_primary_10_1016_j_apjo_2024_100071
crossref_primary_10_1016_j_oret_2025_01_001
crossref_primary_10_1016_j_oftal_2023_11_001
crossref_primary_10_1186_s12886_023_03157_z
crossref_primary_10_1186_s12886_024_03322_y
crossref_primary_10_7759_cureus_49211
crossref_primary_10_1016_j_phrs_2023_106946
crossref_primary_10_1016_j_exger_2024_112581
crossref_primary_10_1016_j_jare_2024_01_016
crossref_primary_10_1038_s41598_023_50738_5
crossref_primary_10_1016_j_molimm_2024_03_009
crossref_primary_10_3389_fphys_2022_956344
crossref_primary_10_1007_s00467_023_06031_8
crossref_primary_10_3390_diagnostics14030317
crossref_primary_10_2174_0115733998274599231109034741
crossref_primary_10_1080_02713683_2024_2430224
crossref_primary_10_2478_amma_2023_0024
crossref_primary_10_1111_ajr_70031
crossref_primary_10_1159_000541294
crossref_primary_10_1016_j_biopha_2023_115726
crossref_primary_10_3389_fmed_2023_1136653
crossref_primary_10_1016_j_bbrep_2024_101807
crossref_primary_10_1016_j_ajo_2024_08_017
crossref_primary_10_2478_rrlm_2023_0028
crossref_primary_10_17343_sdutfd_1268838
crossref_primary_10_2147_DMSO_S480366
crossref_primary_10_1080_02713683_2024_2350590
crossref_primary_10_4103_pajo_pajo_3_23
crossref_primary_10_3390_jcm11010014
crossref_primary_10_1007_s12668_024_01631_6
crossref_primary_10_1007_s00592_023_02105_z
crossref_primary_10_3390_nu15194208
crossref_primary_10_1111_jdi_13997
crossref_primary_10_2147_DMSO_S346719
crossref_primary_10_23736_S2785_1265_22_01854_7
crossref_primary_10_3390_life14070893
crossref_primary_10_1515_biol_2022_0773
crossref_primary_10_3389_fnut_2025_1528383
crossref_primary_10_18359_rmed_7374
crossref_primary_10_3390_jcm13010074
crossref_primary_10_1111_jdi_14042
crossref_primary_10_54393_pjhs_v6i1_2653
crossref_primary_10_1055_a_2239_0123
crossref_primary_10_1016_j_onano_2023_100174
crossref_primary_10_1016_j_ejphar_2024_177021
crossref_primary_10_3390_medicina60081254
crossref_primary_10_1186_s13098_025_01666_z
crossref_primary_10_1016_j_clinthera_2025_02_005
crossref_primary_10_1038_s41746_024_01197_3
crossref_primary_10_4239_wjd_v14_i7_1103
crossref_primary_10_22141_2309_8147_11_1_2023_313
crossref_primary_10_1055_a_1931_4400
crossref_primary_10_17816_OV488056
crossref_primary_10_3390_ijms26010290
crossref_primary_10_1186_s12886_024_03346_4
crossref_primary_10_35339_ekm_2021_90_2_sap
crossref_primary_10_1159_000534271
crossref_primary_10_1111_jcmm_70442
crossref_primary_10_1155_2021_5340453
crossref_primary_10_3390_medicina59010178
crossref_primary_10_7759_cureus_55525
crossref_primary_10_1186_s13098_022_00860_7
crossref_primary_10_1080_09286586_2024_2372045
crossref_primary_10_1186_s12974_023_02983_8
crossref_primary_10_14336_AD_2022_0711
crossref_primary_10_3389_fendo_2024_1412138
crossref_primary_10_1166_jbmb_2024_2402
crossref_primary_10_1186_s12944_024_02064_6
crossref_primary_10_1016_j_biopha_2023_115895
crossref_primary_10_1080_07435800_2024_2364719
crossref_primary_10_1007_s00592_024_02303_3
crossref_primary_10_1007_s12041_023_01443_9
crossref_primary_10_3390_biomedicines11112951
crossref_primary_10_18008_1816_5095_2023_2_283_290
crossref_primary_10_1002_brx2_70005
crossref_primary_10_3389_fendo_2024_1462043
crossref_primary_10_3390_ijerph192114592
crossref_primary_10_3390_pharmaceutics15051413
crossref_primary_10_1111_aos_15788
crossref_primary_10_3389_fendo_2024_1340608
crossref_primary_10_1002_hsr2_1605
crossref_primary_10_1016_j_ecl_2023_09_004
crossref_primary_10_1039_D3NA00327B
crossref_primary_10_3389_fmed_2023_1125062
crossref_primary_10_3390_biomedicines13020341
crossref_primary_10_3390_app13116569
crossref_primary_10_1155_2024_8520489
crossref_primary_10_3389_fendo_2023_1220426
crossref_primary_10_1007_s10528_024_10781_x
crossref_primary_10_3390_ijms241512014
crossref_primary_10_1111_jdi_70011
crossref_primary_10_26724_2079_8334_2023_4_86_57_60
Cites_doi 10.1016/j.ophtha.2010.03.045
10.1016/j.ophtha.2016.02.022
10.1016/j.ophtha.2018.04.007
10.1001/jama.2015.15217
10.1111/jdi.12655
10.1111/jdi.12957
10.1155/2014/805801
10.2337/dc18-2308
10.1038/nrdp.2016.12
10.1016/j.ophtha.2014.07.019
10.2337/dc16-2641
10.1001/jamaophthalmol.2018.3255
10.1111/jdi.12723
10.1111/jdi.13194
10.1111/jdi.12842
10.1016/j.jfma.2019.07.027
10.1111/jdi.12772
10.1111/jdi.12953
10.1056/NEJMct0908432
10.1159/000491897
10.1136/bmj.317.7160.703
10.1016/j.jdiacomp.2015.05.021
10.1080/02713680802585920
10.1016/S2213-8587(16)30052-3
10.1016/j.ophtha.2015.06.017
10.1155/2013/436329
10.1016/S2213-8587(19)30411-5
10.1167/iovs.16-19964
10.2337/dc08-0189
10.1053/ajkd.1998.v31.pm9631838
10.1016/j.ophtha.2011.01.031
10.1371/journal.pone.0121011
10.1056/NEJMoa1414264
10.1056/NEJM199309303291401
10.1111/jdi.13265
10.2337/dc12-1491
10.1046/j.1442-9071.2000.00309.x
10.1016/S2213-8587(15)00136-9
10.1016/j.ophtha.2011.12.039
10.1111/jdi.12770
10.3390/jcm8010121
10.1056/NEJMoa1612836
10.2337/db15-0389
10.1016/S0140-6736(17)31193-5
ContentType Journal Article
Copyright 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd
2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd
– notice: 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
– notice: 2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TM
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1111/jdi.13480
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Nucleic Acids Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
Immunology Abstracts
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Publicly Available Content Database

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Update in diabetes retinopathy
EISSN 2040-1124
EndPage 1325
ExternalDocumentID oai_doaj_org_article_5c97e7b68bfe499186a06673f18436b1
PMC8354492
33316144
10_1111_jdi_13480
JDI13480
Genre article
Journal Article
Review
GroupedDBID ---
05W
0R~
1OC
24P
31~
4.4
50Y
5DZ
5VS
7X7
8-0
8-1
8FI
8FJ
AAHHS
AANHP
AAZKR
ABDBF
ABJNI
ABUWG
ACBWZ
ACCFJ
ACCMX
ACGFO
ACPRK
ACRPL
ACUHS
ACXQS
ACYXJ
ADBBV
ADKYN
ADNMO
ADPDF
ADRAZ
ADZMN
AEEZP
AEGXH
AENEX
AEQDE
AFKRA
AHMBA
AIAGR
AIWBW
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
ASPBG
AVUZU
AVWKF
AZFZN
BAWUL
BCNDV
BDRZF
BENPR
BPHCQ
BVXVI
CAG
CCPQU
COF
DIK
EBD
EBS
EJD
FYUFA
GODZA
GROUPED_DOAJ
GX1
HMCUK
HYE
HZ~
KQ8
LH4
LW6
M48
MY.
O9-
OK1
OVD
PIMPY
PQQKQ
PROAC
RPM
RX1
SUPJJ
TEORI
UKHRP
WIN
AAYXX
AGQPQ
CITATION
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TM
7XB
8FK
AZQEC
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c5330-f8978dfc9bb767efc2253cde670f6e805ad2e72b754f75b887b7b99046de9453
IEDL.DBID M48
ISSN 2040-1116
2040-1124
IngestDate Wed Aug 27 00:54:09 EDT 2025
Thu Aug 21 18:36:27 EDT 2025
Thu Jul 10 17:24:01 EDT 2025
Fri Jul 25 06:18:18 EDT 2025
Mon Jul 21 05:23:04 EDT 2025
Tue Jul 01 02:48:47 EDT 2025
Thu Apr 24 22:52:33 EDT 2025
Wed Jan 22 16:28:34 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Screening
Diabetes retinopathy
Treatment
Epidemiology
Risk factors
Language English
License Attribution-NonCommercial-NoDerivs
2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5330-f8978dfc9bb767efc2253cde670f6e805ad2e72b754f75b887b7b99046de9453
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0001-9437-5847
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1111/jdi.13480
PMID 33316144
PQID 2559688841
PQPubID 1006415
PageCount 4
ParticipantIDs doaj_primary_oai_doaj_org_article_5c97e7b68bfe499186a06673f18436b1
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8354492
proquest_miscellaneous_2470282043
proquest_journals_2559688841
pubmed_primary_33316144
crossref_primary_10_1111_jdi_13480
crossref_citationtrail_10_1111_jdi_13480
wiley_primary_10_1111_jdi_13480_JDI13480
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2021
PublicationDateYYYYMMDD 2021-08-01
PublicationDate_xml – month: 08
  year: 2021
  text: August 2021
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Richmond
– name: Hoboken
PublicationTitle Journal of diabetes investigation
PublicationTitleAlternate J Diabetes Investig
PublicationYear 2021
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2019; 8
2017; 40
2017; 5
1993; 329
2011; 118
2015; 3
2000; 28
2019; 10
2015; 122
1976; 81
2015; 10
2018; 125
1998; 317
2003; 57
2016; 123
2014; 2014
2020; 11
2008; 31
2017; 376
2018; 48
2016; 57
2009; 34
2020; 8
2010; 23
2015; 372
2018; 9
2013; 36
2016; 2
2015; 29
2019; 42
2015; 314
2013; 2013
2010; 117
1981; 197
2018; 136
2016; 65
2019; 118
2014; 121
1998; 31
2017; 389
2011; 365
2012; 119
e_1_2_7_5_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_17_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_13_1
e_1_2_7_11_1
e_1_2_7_45_1
e_1_2_7_47_1
e_1_2_7_26_1
e_1_2_7_49_1
e_1_2_7_28_1
e_1_2_7_50_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_23_1
e_1_2_7_33_1
Diabetic T, Study R (e_1_2_7_43_1) 1976; 81
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_37_1
e_1_2_7_39_1
e_1_2_7_6_1
e_1_2_7_4_1
e_1_2_7_8_1
e_1_2_7_18_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_2_1
e_1_2_7_14_1
e_1_2_7_42_1
e_1_2_7_12_1
Badr H (e_1_2_7_36_1) 2010; 23
e_1_2_7_10_1
e_1_2_7_46_1
e_1_2_7_48_1
e_1_2_7_27_1
e_1_2_7_29_1
Ogata N (e_1_2_7_24_1) 2003; 57
e_1_2_7_30_1
e_1_2_7_32_1
e_1_2_7_22_1
e_1_2_7_34_1
Riaskoff S (e_1_2_7_44_1) 1981; 197
e_1_2_7_20_1
e_1_2_7_38_1
References_xml – volume: 314
  start-page: 2137
  year: 2015
  end-page: 2146
  article-title: Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial
  publication-title: J Am Med Assoc
– volume: 10
  start-page: 753
  year: 2019
  end-page: 759
  article-title: Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes
  publication-title: J Diabetes Investig
– volume: 40
  start-page: 412
  year: 2017
  end-page: 418
  article-title: Diabetic retinopathy: A position statement by the American Diabetes Association
  publication-title: Diabetes Care
– volume: 376
  start-page: 1507
  year: 2017
  end-page: 1516
  article-title: Frequency of evidence‐based screening for retinopathy in type 1 diabetes
  publication-title: N Engl J Med
– volume: 123
  start-page: 1351
  year: 2016
  end-page: 1359
  article-title: Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema two‐year results from a comparative effectiveness randomized clinical trial
  publication-title: Ophthalmology
– volume: 118
  start-page: 615
  year: 2011
  end-page: 625
  article-title: The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema
  publication-title: Ophthalmology
– volume: 10
  start-page: 1
  year: 2015
  end-page: 15
  article-title: Relationship between C‐reactive protein level and diabetic retinopathy: a systematic review and meta‐analysis
  publication-title: PLoS One
– volume: 57
  start-page: 5200
  year: 2016
  end-page: 5206
  article-title: Improved automated detection of diabetic retinopathy on a publicly available dataset through integration of deep learning
  publication-title: Investig Ophthalmol Vis Sci
– volume: 2
  start-page: 16012
  year: 2016
  article-title: Diabetic retinopathy
  publication-title: Nat Rev Dis Prim
– volume: 2013
  start-page: 436329
  year: 2013
  article-title: Body mass index: a risk factor for retinopathy in type 2 diabetic patients
  publication-title: Mediators Inflamm
– volume: 31
  start-page: 947
  year: 1998
  end-page: 953
  article-title: Overt albuminuria predicts diabetic retinopathy in hispanics with NIDDM
  publication-title: Am J Kidney Dis
– volume: 125
  start-page: 1608
  year: 2018
  end-page: 1622
  article-title: Guidelines on diabetic eye care: the International Council of Ophthalmology recommendations for screening, follow‐up, referral, and treatment based on resource settings
  publication-title: Ophthalmology
– volume: 365
  start-page: 1520
  year: 2011
  end-page: 1526
  article-title: Panretinal photocoagulation for proliferative diabetic retinopathy
  publication-title: N Engl J Med
– volume: 48
  start-page: 705
  year: 2018
  end-page: 717
  article-title: Involvement of advanced glycation end products in the pathogenesis of diabetic retinopathy
  publication-title: Cell Physiol Biochem
– volume: 36
  start-page: 1254
  year: 2013
  end-page: 1259
  article-title: Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy
  publication-title: Diabetes Care
– volume: 23
  start-page: 1
  year: 2010
  end-page: 7
  article-title: Massimo Cristofanilli and TAR. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
  publication-title: Ophthalmology
– volume: 9
  start-page: 173
  year: 2018
  end-page: 178
  article-title: Trends in diabetic retinopathy and related medical practices among type 2 diabetes patients: Results from the National Insurance Service Survey 2006–2013
  publication-title: J Diabetes Investig
– volume: 117
  start-page: 1078
  issue: 1078–1086
  year: 2010
  end-page: 1086.e2
  article-title: A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT Study). 12‐Month Data: Report 2
  publication-title: Ophthalmology
– volume: 81
  start-page: 397
  year: 1976
  end-page: 402
  article-title: Preliminary report on effects of photocoagulation therapy
  publication-title: Am J Ophthalmol
– volume: 372
  start-page: 1193
  year: 2015
  end-page: 1203
  article-title: Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema
  publication-title: N Engl J Med
– volume: 136
  start-page: 1138
  year: 2018
  end-page: 1148
  article-title: Five‐Year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial
  publication-title: JAMA Ophthalmol
– volume: 42
  start-page: 875
  year: 2019
  end-page: 882
  article-title: Risk factors for retinopathy in type 1 diabetes: the DCCT/EDIC study
  publication-title: Diabetes Care
– volume: 57
  start-page: 769
  year: 2003
  end-page: 772
  article-title: Unbalanced Vitreous levels of pigment epithelium‐derived factor and vascular endothelial growth factor in diabetic retinopathy
  publication-title: Jpn J Clin Ophthalmol
– volume: 197
  start-page: 9
  year: 1981
  end-page: 17
  article-title: Photocoagulation treatment of proliferative diabetic retinopathy
  publication-title: Ophthalmology
– volume: 11
  start-page: 1170
  year: 2020
  end-page: 1180
  article-title: Combined effect of diabetic retinopathy and diabetic kidney disease on all‐cause, cancer, vascular and non‐cancer non‐vascular mortality in patients with type 2 diabetes: a real‐world longitudinal study
  publication-title: J Diabetes Investig
– volume: 122
  start-page: 2044
  year: 2015
  end-page: 2052
  article-title: Intravitreal aflibercept for diabetic macular edema: 100‐week results from the VISTA and VIVID studies
  publication-title: Ophthalmology
– volume: 389
  start-page: 2193
  year: 2017
  end-page: 2203
  article-title: Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single‐blinded, randomised, controlled, phase 2b, non‐inferiority trial
  publication-title: Lancet
– volume: 11
  start-page: 930
  year: 2020
  end-page: 937
  article-title: Effect of postprandial hyperglycemia at clinic visits on the incidence of retinopathy in patients with type 2 diabetes: an analysis using real‐world long‐term follow‐up data
  publication-title: J Diabetes Investig
– volume: 121
  start-page: 2443
  year: 2014
  end-page: 2451
  article-title: The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the ACCORD eye study
  publication-title: Ophthalmology
– volume: 9
  start-page: 244
  year: 2018
  end-page: 255
  article-title: Metabolomics window into diabetic complications
  publication-title: J Diabetes Investig
– volume: 65
  start-page: 216
  year: 2016
  end-page: 227
  article-title: Angiogenic microRNAs linked to incidence and progression of diabetic retinopathy in type 1 diabetes
  publication-title: Diabetes
– volume: 3
  start-page: 653
  year: 2015
  end-page: 663
  article-title: New ophthalmologic imaging techniques for detection and monitoring of neurodegenerative changes in diabetes: A systematic review
  publication-title: Lancet Diabetes Endocrinol
– volume: 119
  start-page: 789
  year: 2012
  end-page: 801
  article-title: Ranibizumab for diabetic macular edema: Results from 2 phase iii randomized trials: RISE and RIDE
  publication-title: Ophthalmology
– volume: 8
  start-page: 337
  year: 2020
  end-page: 347
  article-title: Screening for diabetic retinopathy: new perspectives and challenges
  publication-title: Lancet Diabetes Endocrinol
– volume: 31
  start-page: 1842
  year: 2008
  end-page: 1846
  article-title: Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes
  publication-title: Diabetes Care
– volume: 28
  start-page: 129
  year: 2000
  end-page: 132
  article-title: Fred hollows lecture: digital screening for eye disease
  publication-title: Clin Exp Ophthalmol
– volume: 10
  start-page: 745
  year: 2019
  end-page: 752
  article-title: Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus
  publication-title: J Diabetes Investig
– volume: 34
  start-page: 152
  year: 2009
  end-page: 161
  article-title: Vitreous and serum levels of platelet‐derived growth factor and their correlation in patients with proliferative diabetic retinopathy
  publication-title: Curr Eye Res
– volume: 29
  start-page: 928
  year: 2015
  end-page: 936
  article-title: Proteomic analysis of plasma proteins in diabetic retinopathy patients by two dimensional electrophoresis and MALDI‐Tof‐MS
  publication-title: J Diabetes Complications
– volume: 9
  start-page: 726
  year: 2018
  end-page: 727
  article-title: Novel strategy for screening of diabetic retinopathy
  publication-title: J Diabetes Investig
– volume: 329
  start-page: 977
  year: 1993
  end-page: 986
  article-title: The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus
  publication-title: N Engl J Med
– volume: 5
  start-page: 143
  year: 2017
  end-page: 155
  article-title: Diabetic macular oedema
  publication-title: Lancet Diab Endocrinol
– volume: 10
  start-page: 6
  year: 2019
  end-page: 17
  article-title: (Pro)renin receptor: involvement in diabetic retinopathy and development of molecular targeted therapy
  publication-title: J Diabetes Investig
– volume: 8
  start-page: 121
  year: 2019
  article-title: Homocysteine: a potential biomarker for diabetic retinopathy
  publication-title: J Clin Med
– volume: 2014
  start-page: 805801
  year: 2014
  article-title: The associations between VEGF gene polymorphisms and diabetic retinopathy susceptibility: a meta‐analysis of 11 case‐control studies
  publication-title: J Diabetes Res
– volume: 118
  start-page: S103
  issue: Suppl. 2
  year: 2019
  end-page: S110
  article-title: Diabetes‐related kidney, eye, and foot disease in Taiwan: an analysis of nationwide data for 2005–2014
  publication-title: J Formos Med Assoc
– volume: 9
  start-page: 946
  year: 2018
  end-page: 951
  article-title: Severity and multiplicity of microvascular complications are associated with QT interval prolongation in patients with type 2 diabetes
  publication-title: J Diabetes Investig
– volume: 317
  start-page: 703
  year: 1998
  end-page: 713
  article-title: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
  publication-title: Br Med J
– ident: e_1_2_7_37_1
  doi: 10.1016/j.ophtha.2010.03.045
– ident: e_1_2_7_42_1
  doi: 10.1016/j.ophtha.2016.02.022
– volume: 197
  start-page: 9
  year: 1981
  ident: e_1_2_7_44_1
  article-title: Photocoagulation treatment of proliferative diabetic retinopathy
  publication-title: Ophthalmology
– ident: e_1_2_7_28_1
  doi: 10.1016/j.ophtha.2018.04.007
– ident: e_1_2_7_49_1
  doi: 10.1001/jama.2015.15217
– ident: e_1_2_7_4_1
  doi: 10.1111/jdi.12655
– ident: e_1_2_7_10_1
  doi: 10.1111/jdi.12957
– ident: e_1_2_7_22_1
  doi: 10.1155/2014/805801
– ident: e_1_2_7_7_1
  doi: 10.2337/dc18-2308
– ident: e_1_2_7_2_1
  doi: 10.1038/nrdp.2016.12
– ident: e_1_2_7_14_1
  doi: 10.1016/j.ophtha.2014.07.019
– ident: e_1_2_7_29_1
  doi: 10.2337/dc16-2641
– ident: e_1_2_7_48_1
  doi: 10.1001/jamaophthalmol.2018.3255
– ident: e_1_2_7_20_1
  doi: 10.1111/jdi.12723
– ident: e_1_2_7_11_1
  doi: 10.1111/jdi.13194
– ident: e_1_2_7_50_1
  doi: 10.1111/jdi.12842
– ident: e_1_2_7_3_1
  doi: 10.1016/j.jfma.2019.07.027
– ident: e_1_2_7_6_1
  doi: 10.1111/jdi.12772
– ident: e_1_2_7_8_1
  doi: 10.1111/jdi.12953
– ident: e_1_2_7_45_1
  doi: 10.1056/NEJMct0908432
– ident: e_1_2_7_18_1
  doi: 10.1159/000491897
– ident: e_1_2_7_12_1
  doi: 10.1136/bmj.317.7160.703
– ident: e_1_2_7_19_1
  doi: 10.1016/j.jdiacomp.2015.05.021
– volume: 57
  start-page: 769
  year: 2003
  ident: e_1_2_7_24_1
  article-title: Unbalanced Vitreous levels of pigment epithelium‐derived factor and vascular endothelial growth factor in diabetic retinopathy
  publication-title: Jpn J Clin Ophthalmol
– ident: e_1_2_7_23_1
  doi: 10.1080/02713680802585920
– ident: e_1_2_7_46_1
  doi: 10.1016/S2213-8587(16)30052-3
– ident: e_1_2_7_40_1
  doi: 10.1016/j.ophtha.2015.06.017
– ident: e_1_2_7_15_1
  doi: 10.1155/2013/436329
– ident: e_1_2_7_30_1
  doi: 10.1016/S2213-8587(19)30411-5
– ident: e_1_2_7_32_1
  doi: 10.1167/iovs.16-19964
– ident: e_1_2_7_26_1
  doi: 10.2337/dc08-0189
– ident: e_1_2_7_13_1
  doi: 10.1053/ajkd.1998.v31.pm9631838
– ident: e_1_2_7_38_1
  doi: 10.1016/j.ophtha.2011.01.031
– ident: e_1_2_7_16_1
  doi: 10.1371/journal.pone.0121011
– ident: e_1_2_7_41_1
  doi: 10.1056/NEJMoa1414264
– ident: e_1_2_7_9_1
  doi: 10.1056/NEJM199309303291401
– ident: e_1_2_7_5_1
  doi: 10.1111/jdi.13265
– ident: e_1_2_7_25_1
  doi: 10.2337/dc12-1491
– ident: e_1_2_7_33_1
  doi: 10.1046/j.1442-9071.2000.00309.x
– volume: 23
  start-page: 1
  year: 2010
  ident: e_1_2_7_36_1
  article-title: Massimo Cristofanilli and TAR. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
  publication-title: Ophthalmology
– ident: e_1_2_7_27_1
  doi: 10.1016/S2213-8587(15)00136-9
– ident: e_1_2_7_39_1
  doi: 10.1016/j.ophtha.2011.12.039
– ident: e_1_2_7_35_1
  doi: 10.1111/jdi.12770
– ident: e_1_2_7_17_1
  doi: 10.3390/jcm8010121
– ident: e_1_2_7_34_1
  doi: 10.1056/NEJMoa1612836
– ident: e_1_2_7_21_1
  doi: 10.2337/db15-0389
– ident: e_1_2_7_47_1
  doi: 10.1016/S0140-6736(17)31193-5
– volume: 81
  start-page: 397
  year: 1976
  ident: e_1_2_7_43_1
  article-title: Preliminary report on effects of photocoagulation therapy
  publication-title: Am J Ophthalmol
– ident: e_1_2_7_31_1
SSID ssj0000388667
Score 2.632934
SecondaryResourceType review_article
Snippet Despite progress in the treatment of diabetic macular edema and diabetic retinopathy, the rate of lower fundus examination due to limitations of medical...
Despite the above mentioned risk factors, studies revealed a substantial variation in the development and severity of diabetic retinopathy that could not be...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1322
SubjectTerms Automation
Biomarkers
Blood pressure
Clinical medicine
Clinical trials
Diabetes
Diabetes mellitus
Diabetes Mellitus - epidemiology
Diabetes retinopathy
Diabetic retinopathy
Diabetic Retinopathy - diagnosis
Diabetic Retinopathy - epidemiology
Diabetic Retinopathy - therapy
Edema
Epidemiology
Humans
Hyperglycemia
Hypertension
JDI Updates
Lasers
Mass Screening
Neurodegeneration
Prevalence
Retinopathy
Risk Factors
Screening
Telemedicine
Treatment
Vascular endothelial growth factor
Vision
Visual impairment
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iQbyIb9cXUTx42Oq2SZP06BMV9KQgXkrTTLAg3cXHwX_vTFrrLipevJUmh3Qyk5mv_TofY3sSMhcTe8YOQEXoIUVkUguRls7EKcSggnzb9Y26uJNX9-n9mNQXccKa9sCN4Q7TMtOgrTLWA1bnsVFFkKr0JFSibAA-mPPGwFQ4g4UxKsjHJkSZw4BWbVuhQONx1UEsJLWCHEtGoWf_T4Xmd77keB0bEtH5PJtrK0h-1Kx8gU1Bvchmrttv5Evs4W5EKJ5XNcfijsOXBOx7nxOTnLcaO32ORwbCWExefV7Ujnekcz70vHkpW5WcfnOsh6Rc_L7Mbs_Pbk8uolZBISqJNRp5gyDR-TKzVisNvsToFaUDpQdegRmkhUtAJ1an0uvU4oFjtcX8JJWDTKZihU3XwxrWGC-0l5jpFSS2lEVsrPFYndH_R4mDRIge2_-0ZF623cVJ5OIp71CGq_Jg9B7b7aaOmpYaP006pu3oJlAX7HADfSNvfSP_yzd6bPNzM_M2NF9ywlAKcb_E4Z1uGIOKvpQUNQzfcI7UhEUHEp9rtdn7biVCiJhQdI_pCa-YWOrkSF09hsbd9JJNZgnaKvjP70-fX51ehov1_zDDBptNiIkTaIubbPr1-Q22sJR6tdshaj4AfWgYJQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BkRAXxJuUggziwGED68SxkxPiVZVK5dRKKy5RbI9LJJRsX4f-e2a83rQrCrco8SF-jOfhz98H8FZh4yWjZ-wcdU4rpMvrymJulK9lhRJ1lG87-KH3jtT-olqkgttZglWu98S4UfvRcY38A4e-mtI1JT8uT3JWjeLT1SShcRvuMHUZQ7rMwkw1FmY60VFEtmDgHJm1TuRCEczj-_eyVEwIec0lReb-m8LNv1GT16PZ6I52H8D9FEeKT6uJfwi3cHgEdw_SSflj-Hm05Fxe9IOgEE_glRDs5UwwnlwkpZ2ZoI2DkllyYTPRDV5M0HMxBrEqzfZO8GXHYWT94ssncLj77fDLXp50FHLH2NE81JQq-uAaa402GBzZcOk8ajMPGut51fkCTWFNpYKpLG071ljyUkp7bFRVPoWtYRzwOYjOBEX-XmNhnepkbetAMRrfQio8FmWZwbv1SLYucYyz1MXvdso1fN_GQc_gzdR0uSLWuKnRZ56OqQFzYccX4-lxm0yrrVxj0Fhd24CUv8lad1HMNLCUjbYyg531ZLbJQM_aq-WUwevpM5kWn5d0A44X1EYZzkjnivr1bDX305-UZSk5l87AbKyKjV_d_DL0vyJ9N5faVFPQWMX18-_et_tfv8eH7f_34AXcKxhpE2GJO7B1fnqBLylUOrevoj38AZ0_EJg
  priority: 102
  providerName: ProQuest
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3BTtwwELVWVEK9oLa0sGWpDOLQwwZtHMd2xAnaIkAC9QAS4hLF8RgioWTFwoG_Z8bJhl0VpN6ieCIltsczz3mex9iehMzFxJ6xE1ARzpAiMqmFSEtn4hRiUEG-7fxCnVzJs-v0esAO5mdh2voQ_YYbeUZYr8nBCztbdHJX7ceJNIjXP9DRWiqcL-TffoOFypyooCAriDWHD6muslBg8syfXopHoWz_W7nmv5TJxVQ2xKLjT2ytSyL5YTvqn9kA6i9s9bz7Tb7Obq6mBOR5VXPM7zi8qsA-jzmRyXknszPmuGogksX4NeZF7XjPO-eN5-2-bFVyOulYNyRe_PyVXR7_ufx1EnUiClFJxNHIG8SJzpeZtVpp8CU6cFI6UHriFZhJWjgBWlidSq9Ti2uO1RZDlFQOMpkm39hK3dSwyXihvcRgr0DYUhaxscZjgkZHkIQDkSRD9nPek3nZFRgnnYv7vAcarspDpw_Zbm86batqvGV0RMPRG1Ah7HCjebjNO7_K0zLToK0y1gOCt9ioIiiZetKxUTYestF8MPPOO2c5wSiF0F9i807fjH5FP0uKGpontJGa4OhE4ndttGPfv0mSJDEB6SHTS7Ni6VWXW-rqLtTupn02mQnsqzB_3v_6_Oz3abj4_v-mW-yjIMpN4CeO2MrjwxNsY870aH8E33gBnHAQZw
  priority: 102
  providerName: Wiley-Blackwell
Title Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjdi.13480
https://www.ncbi.nlm.nih.gov/pubmed/33316144
https://www.proquest.com/docview/2559688841
https://www.proquest.com/docview/2470282043
https://pubmed.ncbi.nlm.nih.gov/PMC8354492
https://doaj.org/article/5c97e7b68bfe499186a06673f18436b1
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED66Fkpfxn4vXRe0sYc9xCW2ZUl-GGPdWrpCShkNhL0Yy5I2Q7HbrIXlv9-dInszy172YoIlE1u6090nf74P4A23uYmJPaOnVkRoIWWkMm0jyY2KMxtb4eXbZufidM7PFtliCzqNzTCAPzZCO9KTmi-vDn_erN6jw7_rWTmmPoxTrhC572BAkuSfs5Dl-wU5VUp4LdmE-HN4iQg1hgZX78FumqYxIaRBkPK1_DcloH_zKP_Mb32AOnkA90NmyT6sTeEhbNnmEezOwrvzx_B1fk3ontUNw6SP2d_SsKsJI4Y5C9o7E4ZLCcJbDGoTVjaG9WR01jq23qytK0afPzYtKRqvnsDlyfHlx9MoKCtEFbFJI6cQPBpX5VpLIa2r0KvTylghp05YNc1Kk1iZaJlxJzONC5GWGuMWF8bmPEufwnbTNvY5sFI6jhmAsImueBkrrRxmbfRdUmJskqYjeNuNZFGFquMkfnFV9OjD1IUf_xG87rter0ttbOp0RNPRd6Dq2P5Eu_xWBGcrsiqXVmqhtLOI6GIlSi9v6kjcRuh4BAfdZBadxRWErYRSimPzq74ZnY3eoJSNbe-wD5eEUaccn-vZeu77O-lsZwRyYBWDWx22NPV3X9CbNt94nuBYefv599MXZ58--x_7__0nL2AvIVqO5zAewPbt8s6-xLzqVo_hXsIv8CgXcgw7R8fnF1_Gfo9i7P3pFwMYI8c
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqrQRcEG8CBQwCicMGNo5jJweEKG2123ZXCG2lqhcrju02EkqWPoT2R_EfmXEe7YrCrbco9sGPmfHM-PN8hLzlNjMRomf0yIoQJCQP00TbUHKTRomNrPD0bdOZGB_w3cPkcI387t7CIKyys4neUJu6wBz5R3R9BYRrPPq8-BkiaxTernYUGo1Y7NnlLwjZzj5NtmB_3zG2sz3_Og5bVoGwQCRl6FIInIwrMq2lkNYVINFxYayQIydsOkpyw6xkWibcyUSDEmqpwWZzYWzGkSQCLP46jyGSGZD1ze3Zt-99UgdLqwjPWssQqQd2RLTVjDx6yJQfophjBcorZ6CnCrjOv_0bpnnVffbn3849crd1XOmXRtLukzVbPSC3pu3V_ENydLDA5AEtKwo-JbWXzLPLIUUAO22pfYYULBVEz3BmDmleGdpj3WntaJMLLguKryurGgmTl4_I_CaW-DEZVHVlnxKaS8fBwRCW6YLnUapTB04hPntixrI4Dsj7biVV0RY1R26NH6oPbkyp_KIH5E3fddFU8riu0yZuR98Bi2_7H_XpsWp1WSVFJq3UItXOQsAYpSL37KkOuXOEjgKy0W2mai3CmbqU34C87ptBl_GCJq9sfQF9uMQQeMRhXk-ave9HEsdxhMF7QOSKVKwMdbWlKk98vXDM7fGMwVp5-fn37NXu1sR_PPv_DF6R2-P5dF_tT2Z7z8kdhjAfj4ncIIPz0wv7Avy0c_2y1Q5K1A3r4x9Yv04Z
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIlVcUHkHChgEEocNXTuOnRwQApZVt6UVh1ZacbHi2C6RqmTpQ2h_Gv-OGefRrijceotiH_yYGc-MP89HyGvhcssQPWPGTsYgIUWcpcbFStiMpY45Gejb9g_kzpHYnafzNfK7fwuDsMreJgZDbZsSc-Tb6PpKCNcE2_YdLOLbZPph8TNGBim8ae3pNFoR2XPLXxC-nb2fTWCv33A-_XL4eSfuGAbiElGVsc8giLK-zI1RUjlfgnQnpXVSjb102TgtLHeKG5UKr1IDCmmUAfstpHW5QMIIsP63VJIyVDE1V0N6B4usyMBfyxGzBxZFdnWNAo7IVu9YIrAW5ZXTMJAGXOfp_g3YvOpIh5NwuknudC4s_djK3F2y5up7ZGO_u6S_T74fLTCNQKuagndJ3SUH7XJEEcpOO5KfEQWbBXE0nJ4jWtSWDqh32njaZoWrkuI7y7pB6uTlA3J4Ewv8kKzXTe0eE1ooL8DVkI6bUhQsM5kH9xAfQHHreJJE5G2_krrsypsjy8aJHsIcW-mw6BF5NXRdtDU9ruv0Cbdj6IBluMOP5vRYd1qt0zJXThmZGe8gdGSZLAKPqkcWHWlYRLb6zdSdbTjTl5IckZdDM2g1XtUUtWsuoI9QGAyPBczrUbv3w0iSJGEYxkdErUjFylBXW-rqR6gcjlk-kXNYqyA__5693p3MwseT_8_gBdkALdRfZwd7T8ltjnifAI7cIuvnpxfuGThs5-Z5UA1K9A2r4h9B9FDp
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Update+in+the+epidemiology%2C+risk+factors%2C+screening%2C+and+treatment+of+diabetic+retinopathy&rft.jtitle=Journal+of+diabetes+investigation&rft.au=Lin%2C+Kuan%E2%80%90Yu&rft.au=Hsih%2C+Wen%E2%80%90Hui&rft.au=Lin%2C+Yen%E2%80%90Bo&rft.au=Wen%2C+Chen%E2%80%90Yu&rft.date=2021-08-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=2040-1116&rft.eissn=2040-1124&rft.volume=12&rft.issue=8&rft.spage=1322&rft.epage=1325&rft_id=info:doi/10.1111%2Fjdi.13480&rft_id=info%3Apmid%2F33316144&rft.externalDocID=PMC8354492
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2040-1116&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2040-1116&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2040-1116&client=summon